Work

Phase I/II Trial Of Everolimus, Bortezomib and Rituximab In Relapsed Or Relapsed/Refractory Waldenstrom's Macroglobulinemia

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.4402.4402

Authors: Irene M. Ghobrial, Erica N Boswell, Stacey Chuma, Ranjit Banwait, Courtney Hanlon, Houry Leblebjian, Diane Warren, Patrick Mostyn, Farzana Masood, Paul G. Richardson, Steven Peter Treon, Jeffrey Matous

Institutions: Dana-Farber Cancer Institute, Harvard University, Dana-Farber/Harvard Cancer Center, Colorado Blood Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2300611193

FWCI: 0.742

Cites:

Cited by: 5

Related to: 10